RSS

Issue 19.2

The pharmaceutical industry risks high financial penalties if it doesn’t prioritise its environmental reporting obligations. Read more

News

A cloud-based end-to-end warehouse compliance solution has been released to help pharma companies better comply with the EU Falsified Medicines Directive (FMD) and US Drug Supply Chain Security Act (DSCSA). Read more

News

A new genetic test has been developed to help determine whether people carry bacteria that can cause resistance to two common antibiotics. Read more

News

Tony Rhodes, sales manager at Telstar's Technology Centre for Barrier Isolation System discusses what operating pressure manufacturers should choose during the aseptic processing of potent materials in isolators. Read more

Opinion

Erick Gaussens, ProductLife Group’s chief scientific officer, reports on a recent pharmaceutical roundtable which examined why streamlining data management between regulatory and manufacturing needs is a pressing concern for manufacturers. Read more

Opinion

As temperature control packaging companies develop solutions that answer tighter regulations governing wide-stability products, Clive Bryant, global product and marketing director for Softbox Systems, looks at the challenges they must face. Read more

Opinion

Sanjay Vyas, corporate vice president & Global SBU head of Clinical Trial Supplies & Logistics, PAREXEL International discusses the challenges in transporting certain medicines and how advancements in technology are making things easier. Read more

Opinion

In the first article of our new ‘From the Factory’ series, Ajit Kanetkar, head of process technology & training at ACG explains why adopting new technologies is not always a swift transition. Read more

Opinion

David O’Connell, director of Scientific Affairs at PCI Pharma Services looks at the ways in which pharmaceutical manufacturers can overcome challenges in potent compound granulation. Read more

Opinion

Dr Andrew Naylor, research and development director, Upperton Pharma Solutions, explains why spray drying might be the preferred method for biotherapeutics. Read more

Opinion

Here EPM speaks to a number of major pharma players to get their thoughts on what FMD means for the industry. Read more

Opinion

Andrew Turner, regional sales manager, Hanningfield Asia-Pacific, looks back at the success of capsule transfer systems, and why they’re a must have for any manufacturer. Read more

Opinion

Carla Balch, CEO of TransMed Systems discusses the recruitment problems in clinical trials and what technology can do to help. Read more

Opinion

A new wearable could mark the future for clinical trials through the better use of real-world evidence to support the approval of new therapies. Read more

News

The March/April issue of EPM is available for download with all the regulars and features on digital health, containment and our new regular slot 'from the factory'. Read more

Latest Issue

Phil Morton, chief technical officer, Albumedix discusses the effects that albumin can infer on APIs in formulations, and the proposed mechanism behind them. Read more

Opinion

Peter Nelson, technical operations director at Catalent Micron Technologies examines why micronisation may be the answer to poor water solubility in drugs. Read more

News

At this year's Pharmapack, Reece Armstrong caught up with event director Silvia Forroova to discuss why the show has grown so much and what to expect from the industry in 2019. Read more

Opinion

Dr Peter Fish, head of clinical partnerships at Mendelian discusses why artificial intelligence (AI) could be the key to diagnosing rare diseases. Read more

Opinion

Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma. Read more

Opinion